BioNTech SE (BNTX) Enterprise Value (2019 - 2026)

BioNTech SE has reported Enterprise Value for 8 years, with the latest figure at -$18.4 billion in Q4 2025.

• Quarterly Enterprise Value rose 5.67% year-over-year to -$18.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.4 billion (up 5.67% YoY) and the FY2025 annual result came in at -$17.9 billion, up 8.44% from the prior year.
• Enterprise Value slipped to -$18.4 billion in Q4 2025 per BNTX's latest filing, from -$17.0 billion in the prior quarter.
• Over five years, Enterprise Value peaked at -$432.8 million in Q3 2021 and troughed at -$19.5 billion in Q4 2024.
• A 5-year average of -$12.1 billion and a median of -$15.4 billion in 2025 frame the typical range for Enterprise Value.
• The widest YoY moves for Enterprise Value: up 15.45% in 2022, down 3039.57% in 2022.
• Over 5 years, Enterprise Value stood at -$2.4 billion in 2021, then slumped by 504.7% to -$14.3 billion in 2022, then decreased by 24.09% to -$17.8 billion in 2023, then dropped by 9.51% to -$19.5 billion in 2024, then advanced by 5.67% to -$18.4 billion in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$18.4 billion, -$17.0 billion, and -$15.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.